On July 1, 2026, clinical coordinators in Australia released updated guidelines for patients importing advanced biologics under the Therapeutic Goods Administration (TGA) Personal Importation Scheme. The scheme provides a critical lifeline for patients requiring immediate access to targeted immunotherapies like Keytruda and Herceptin that may face local PBS delays or shortages.

At Onco Medicine, we specialize in delivering authentic, tracked oncology medications to patients and clinics across Australia. Sourcing original medicines under TGA rules ensures clinical continuity and peace of mind.

Navigating the TGA Importation Framework

• Valid Prescription Requirement: Sourcing under the scheme requires a valid prescription from an Australian-registered medical practitioner.
• Strict Limits: Patients may import up to a 3-month supply per order, with a maximum of 15 months' supply per calendar year.
• Long-Distance Cold-Chain: Due to Australia's geographic distance, shipping temperature-sensitive immunotherapies requires robust thermal insulation and real-time data loggers.

Geographic location should never limit access to oncology care. By ensuring thorough documentation, batch verification, and secure shipping to major cities and regional areas, Onco Medicine remains Australia's trusted pharmaceutical import partner.